Mirror Now
@mirrornow·2.2M subscribers·145K videos
Tata Group's first low-cost COVID-19 test 'Feluda' to be launched, Crispr technology to be used
Posted
September 20, 2020
Views
711
Likes
12
Comments
5
Engagement
September 20, 2020
711
12
5
2.39%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
1:17Now PlayingIndia's first low-cost COVID-19 test all set to be launched. The test which goes by the name 'Feluda' has been developed by the Tata Group. The Drug Controller General of India has given its approval for the commercial launch of this test.
COVID-19 test 'Feluda' uses the Crispr technology for detection which helps in the detection of the coronavirus. According to the Ministry of Science and Technology, this test uses an indigeniously developed cutting-edge technology which helps in the detection of the coronavirus. Tata Group has gotten the approval for the commercial launch of this test and it is the first low-cost test.
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
